News & Updates

The costs of all-cause and psychiatric care for depression are projected to reach HKD 2.5 billion annually by 2032, with HKD 473.5 million specifically attributable to psychiatric care, according to a 10-year predictive modelling study based on real-world data.

Asia’s first histotripsy 2.0 system, introduced at the Chinese University Hong Kong (CUHK) recently, will be used in clinical trials to treat liver cancer patients from early 2025. The novel focal therapy will also be evaluated in patients with early-stage breast cancer.